This is a non-core endpoint: only basic statistics are computed.
Hyperimmunoglobulin E [IgE] syndrome
DOID EFO MESH Endpoint Browser
D3_HYPERIGESDR
obsolete_Job's syndrome: ['Primary immunodeficiency syndrome characterized by recurrent infections and hyperimmunoglobulinemia E. Most cases are sporadic. Of the rare familial forms, the dominantly inherited subtype has additional connective tissue, dental and skeletal involvement that the recessive type does not share.']
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
18
Check minimum number of events None
18
Include endpoints None
18
Remove individuals based on genotype QC
17
D3_HYPERIGESDR
Control definitions
Control exclude
D3_IMMUNEMECHANISM
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D82
Name in latin
Syndroma hyperimmunoglobulini E (IgE)
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Hyperimmunoglobulin E [IgE] syndrome
based on the number of shared cases.
Broader endpoints:
- Immunodeficiency associated with other major defects
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 17 | 11 | 6 |
| Unadjusted prevalence (%) | 0.00 | 0.00 | 0.00 |
| Mean age at first event (years) | 40.21 | 35.77 | 48.36 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: D3_HYPERIGESDR – Hyperimmunoglobulin E [IgE] syndrome
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Hyperimmunoglobulin E [IgE] syndrome
↥Endpoint not on priority list, no data to show.